EGFR and astrocytoma (excluding glioblastoma): A recent study suggested that EGFR Amp in WHO grade 4 IDH-mutant astrocytoma was not related to worse OS, unless CDKN2A/B homozygous deletion were also detected (Li et al., 2019).